单克隆抗体市场基于(主要区域、市场参与者、规模和份额)- 预测至 2028 年

  • Report Code : TIPRE00026641
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 163
Buy Now

Monoclonal Antibodies Market Size, Value, Share, Segment 2028

Buy Now

单克隆抗体市场规模预计将从 2021 年的 1110.1 亿美元增至 2028 年的 2430.5 亿美元;预计 2021 年至 2028 年的复合年增长率为 11.8%。

癌症和其他慢性疾病的发病率不断上升,以及各地区 COVID-19 病例的大幅增加是推动市场增长的关键因素。根据世界癌症研究基金会和美国癌症研究所的数据,2020 年,全球共记录了约 1810 万例癌症病例,其中男性 930 万例,女性 880 万例。单克隆抗体在治疗各种癌症方面的应用仍处于 2 期和 3 期试验阶段。

2021-2028 年期间,北美很可能继续在 单克隆抗体市场占据主导地位。美国在该地区占有最大的市场份额,预计在预测期内将继续成为市场的主要股东。根据 Globocan 2020 发布的统计数据,美国诊断出约 1,806,590 例新癌症病例,约 606,520 人死于该疾病。根据美国商务部的一份报告,其国家标准与技术研究所 (NIST) 宣布向国家生物制药制造创新研究所提供 1.53 亿美元的资助。此外,FDA 一直在 COVID-19 流行期间扩大对单克隆抗体开发的支持。

 

 

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

单克隆抗体市场:

Monoclonal Antibodies Market: Strategic Insights

Monoclonal Antibodies Market

  • CAGR (2021 - 2028)
    11.8%
  • Market Size 2021
    US$ 111.01 Billion
  • Market Size 2028
    US$ 243.05 Billion

Market Dynamics

GROWTH DRIVERS
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX
FUTURE TRENDS
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX
OPPORTUNITIES
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX

Key Players

  • Novartis AG
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Amgen, Inc
  • Daiichi Sankyo Company, Limited
  • F. Hoffmann-La Roche AG
  • AstraZeneca
  • Elli Lilly and Company
  • Bayer AG

Regional Overview

  • 北美(美国、加拿大、墨西哥)
  • 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
  • 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
  • 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
  • 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)

Market Segmentation

来源(人类、人源化、嵌合体和鼠类)
    生产方法(体外和体内)
      适应症(癌症、自身免疫性疾病、传染病、炎症性疾病、微生物疾病等)
        应用(治疗应用、诊断应用和研究应用)

          单克隆抗体市场

          • 复合年增长率(2021 - 2028 年)
            11.8%
          • 2021 年市场规模
            1110.1 亿美元
          • 2028 年市场规模
            2430.5 亿美元

          市场动态

          增长动力
          • 財政部
          • 財政部
          • 財政部
          未来的趋势
          • 財政部
          • 財政部
          • 財政部
          机会
          • 財政部
          • 財政部
          • 財政部

          关键人物;主力;重要一员

          •  
          • 诺华公司
          • 辉瑞公司
          • 葛兰素史克公司
          • 安进公司
          • 第一三共株式会社
          • F.霍夫曼-拉罗氏公司
          • 阿斯利康
          • 礼来公司
          • 拜耳公司

          区域概况

          • 北美
          • 欧洲
          • 亚太
          • 南美洲和中美洲
          • 中东和非洲

          市场细分

          来源
          • 人类
          • 人性化
          • 嵌合
          • 鼠类
          生产方法
          • 体外和体内
          指征
          • 癌症
          • 自身免疫性疾病
          • 传染性疾病
          • 炎症性疾病
          • 微生物疾病
          • 其他的
          应用
          • 治疗应用
          • 诊断应用
          • 研究应用
          • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

           

          市场洞察

           

          癌症和其他慢性疾病患病率大幅上升推动市场增长

          根据美国癌症协会的报告,截至 2019 年 1 月,美国有约 1690 万名有癌症病史的人。到 2030 年 1 月,仅人口增长和老龄化就估计癌症幸存者的数量将增加到 2210 万。因此,随着癌症和其他慢性疾病的发病率不断上升,对单克隆抗体 (mAB) 等生物制剂的需求也激增。作为许多治疗方案和成本效益治疗的主要组成部分,生物制剂在癌症治疗中发挥着关键作用。

           

          基于来源的洞察

          根据来源,单克隆抗体市场细分为鼠类、嵌合体、人类和人源化。预计人类部分将在 2021-2028 年期间占据最大的市场份额。该细分市场的市场增长归因于人类单克隆抗体在治疗各种传染病方面的整合。例如,Regeneron 推出了 FDA 批准的抗体鸡尾酒 casirivimab 和 imdevimab,用于治疗 COVID-19。该药物已获得 FDA 的紧急使用授权 (EUA)。它用于治疗成人轻度至中度 COVID-19 以及年龄至少 12 岁、体重至少 40 公斤的儿科患者。此外,它们在各种慢性疾病中的使用增加以及先进基因工程技术的采用是推动该细分市场增长的重要因素之一。

           

          基于指示的见解

          根据适应症,癌症、自身免疫性疾病、炎症性疾病、传染病、微生物疾病等。癌症领域将在未来几年占据市场主导地位。单克隆抗体治疗应用方面的进展使其能够成功应用于治疗各种癌症类型,例如乳腺癌、肺癌和结肠癌。基于这些抗体的药物有助于标记癌细胞、触发细胞膜破坏、阻断免疫系统抑制剂等。2020 年 6 月,FDA 批准了两种药物——奥拉帕尼和鲁卡帕尼用于治疗前列腺癌。该药对前列腺癌已扩散或转移且对标准激素治疗无反应(即去势抵抗性疾病)的男性特别有效。

           

          基于最终用户的见解

          根据终端用户,单克隆抗体市场分为医院、研究机构和其他。医院部分占据最大的市场份额,因为越来越多人采用单克隆抗体作为首选治疗方式,尤其是癌症治疗。

           

          在单克隆抗体市场运营的公司采用产品创新战略来满足全球不断变化的客户需求,这也使他们能够在全球市场上保持自己的品牌名称。

           

          单克隆抗体市场报告范围

          报告属性细节
          2021 年市场规模1110.1亿美元
          2028 年市场规模2430.5亿美元
          全球复合年增长率(2021 - 2028)11.8%
          历史数据2019-2020
          预测期2022-2028
          涵盖的领域按来源
          • 人类
          • 人性化
          • 嵌合
          • 鼠类
          按生产方式
          • 体外和体内
          按适应症
          • 癌症
          • 自身免疫性疾病
          • 传染性疾病
          • 炎症性疾病
          • 微生物疾病
          • 其他的
          按应用
          • 治疗应用
          • 诊断应用
          • 研究应用
          覆盖地区和国家北美
          • 我们
          • 加拿大
          • 墨西哥
          欧洲
          • 英国
          • 德国
          • 法国
          • 俄罗斯
          • 意大利
          • 欧洲其他地区
          亚太
          • 中国
          • 印度
          • 日本
          • 澳大利亚
          • 亚太其他地区
          南美洲和中美洲
          • 巴西
          • 阿根廷
          • 南美洲和中美洲其他地区
          中东和非洲
          • 南非
          • 沙特阿拉伯
          • 阿联酋
          • 中东和非洲其他地区
          市场领导者和主要公司简介
          •  
          • 诺华公司
          • 辉瑞公司
          • 葛兰素史克公司
          • 安进公司
          • 第一三共株式会社
          • F.霍夫曼-拉罗氏公司
          • 阿斯利康
          • 礼来公司
          • 拜耳公司
          • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

           

          单克隆抗体市场 - 细分

          根据来源,单克隆抗体市场细分为人类、人源化、嵌合和鼠类。根据生产方法,市场细分为体外和体内。根据适应症,单克隆抗体市场进一步细分为癌症、自身免疫性疾病、传染病、炎症性疾病、微生物疾病和其他。根据应用,市场细分为治疗应用、诊断应用和研究应用。此外,根据最终用户,市场细分为医院、其他和研究机构。

          单克隆抗体市场 - 按地区划分

          • 北美
            • 我们
            • 加拿大
            • 墨西哥
          • 欧洲
            • 法国
            • 德国
            • 意大利
            • 英国
            • 西班牙
            • 欧洲其他地区
          • 亚太地区 (APAC)
            • 中国
            • 印度
            • 韩国
            • 日本
            • 澳大利亚
            • 亚太地区其他地区
          • 中东和非洲 (MEA)
            • 南非
            • 沙特阿拉伯
            • 阿联酋
            • MEA 其他地区
          • 南美洲和中美洲(SCAM)
            • 巴西
            • 阿根廷
            • 其余的骗局

          公司简介

          • 诺华公司
          • 辉瑞公司
          • 葛兰素史克公司
          • 安进公司
          • 第一三共株式会社
          • F.霍夫曼-拉罗氏公司
          • 阿斯利康
          • 艾莉莉莉公司
          • 拜耳公司
          • 百时美施贵宝公司

           

          Monoclonal Antibodies Market Report Scope

          Report Attribute Details
          Market size in US$ 111.01 Billion
          Market Size by US$ 243.05 Billion
          Global CAGR 11.8%
          Historical Data 2019-2020
          Forecast period 2022-2028
          Segments Covered By 来源(人类、人源化、嵌合体和鼠类)
          By 生产方法(体外和体内)
          By 适应症(癌症、自身免疫性疾病、传染病、炎症性疾病、微生物疾病等)
          By 应用(治疗应用、诊断应用和研究应用)
          Regions and Countries Covered 北美(美国、加拿大、墨西哥)
          • 北美(美国、加拿大、墨西哥)
          欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
          • 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
          亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
          • 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
          南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
          • 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
          中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
          • 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
          Market leaders and key company profiles
        • Novartis AG
        • Pfizer Inc.
        • GlaxoSmithKline plc
        • Amgen, Inc
        • Daiichi Sankyo Company, Limited
        • F. Hoffmann-La Roche AG
        • AstraZeneca
        • Elli Lilly and Company
        • Bayer AG
        • Report Coverage
          Report Coverage

          Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

          Segment Covered
          Segment Covered

          This text is related
          to segments covered.

          Regional Scope
          Regional Scope

          North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

          Country Scope
          Country Scope

          This text is related
          to country scope.

          Frequently Asked Questions


          What are the driving factors for the monoclonal antibodies market across the globe?

          Significant rise in the cancer and chronic diseases is one of the most significant factors responsible for the overall market growth.

          Which segment led the monoclonal antibodies market?

          Based on source, human segment took the forefront lead in the worldwide market by accounting largest share in 2020 and is expected to continue to do so till the forecast period.

          What is meant by the monoclonal antibodies market?

          Food and Drug Administration (FDA) defines monoclonal antibodies as immunoglobulin molecules that are secreted from a population of identical cells. They are homogenous in structure and binding specificity. These are used as multifunctional components for the immune system. They facilitate numerous cellular and humoral reactions to a variety of antigens, which include host and foreign substances.

          Which production method segment held the largest revenue (US$ Mn) in the monoclonal antibodies market?

          The in vitro segment dominated the global monoclonal antibodies market and accounted for the largest revenue of 75,044.50 Mn in 2021.

          What is the regional market scenario of the monoclonal antibodies market?

          Global monoclonal antibodies market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, the U.S. is the largest market for monoclonal antibodies market. The US is estimated to hold the largest share in the monoclonal antibodies market during the forecast period. The presence of top players and favorable regulations related to product approvals coupled with commercializing new products are the contributing factors for the regional growth. Additionally, the increasing number of R&D activities is the key factor responsible for the Asia-Pacific regional growth for monoclonal antibodies accounting fastest growth of the region during the coming years.

          Who are the key players in the monoclonal antibodies market?

          Novartis AG, Pfizer, Inc., GlaxoSmithKline Plc, Amgen, Inc., Daiichi Sankyo Company, Limited, F.Hoffmann-La Roche AG, AstraZeneca, Elli Lilly and Company, Bayer AG, Bristol-Myers Squibb Company are among the leading companies operating in the global monoclonal antibodies market

          The List of Companies - Monoclonal Antibody Market

          1. Novartis AG
          2. Pfizer Inc.
          3. GlaxoSmithKline plc
          4. Amgen, Inc
          5. Daiichi Sankyo Company, Limited
          6. F. Hoffmann-La Roche AG
          7. AstraZeneca
          8. Elli Lilly and Company
          9. Bayer AG
          10. Bristol-Myers Squibb Company

          The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

          1. Data Collection and Secondary Research:

          As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

          Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

          1. Primary Research:

          The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

          For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

          A typical research interview fulfils the following functions:

          • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
          • Validates and strengthens in-house secondary research findings
          • Develops the analysis team’s expertise and market understanding

          Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

          • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
          • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

          Below is the breakup of our primary respondents by company, designation, and region:

          Research Methodology

          Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

          1. Data Analysis:

          Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

          • Macro-Economic Factor Analysis:

          We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

          • Country Level Data:

          Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

          • Company Profile:

          The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

          • Developing Base Number:

          Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

          1. Data Triangulation and Final Review:

          The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

          We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

          We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

          Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

          Related Reports